2023 - Research.com Immunology in Mexico Leader Award
Donato Alarcón-Segovia focuses on Immunology, Lupus erythematosus, Internal medicine, Antibody and Systemic disease. The concepts of his Immunology study are interwoven with issues in Autoimmune thyroiditis and Pathology. Donato Alarcón-Segovia combines subjects such as Systemic lupus erythematosus, Disease, Connective tissue disease and Cohort with his study of Lupus erythematosus.
His studies in Internal medicine integrate themes in fields like Gastroenterology and Surgery. His work deals with themes such as Cell, Hemolytic anemia, Receptor, Peripheral blood mononuclear cell and Cytotoxic T cell, which intersect with Antibody. His Systemic disease research is multidisciplinary, incorporating perspectives in Thrombosis and Vasculitis.
His primary scientific interests are in Immunology, Antibody, Internal medicine, Lupus erythematosus and Autoantibody. Immunology and Systemic lupus erythematosus are frequently intertwined in his study. The Antibody study combines topics in areas such as Molecular biology and Peripheral blood mononuclear cell.
His Peripheral blood mononuclear cell research is multidisciplinary, relying on both Receptor and In vivo. Donato Alarcón-Segovia works mostly in the field of Internal medicine, limiting it down to concerns involving Endocrinology and, occasionally, Lymphocyte. In his study, Dermatology is strongly linked to Systemic disease, which falls under the umbrella field of Lupus erythematosus.
His main research concerns Immunology, Internal medicine, Lupus erythematosus, Autoantibody and Antibody. His Immunology research includes themes of Systemic lupus erythematosus, Disease and Allele frequency. His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Endocrinology.
His Lupus erythematosus research incorporates elements of Single-nucleotide polymorphism and Locus. His Autoantibody research is multidisciplinary, incorporating elements of Molecular biology, Protein S, Protein C and Pathogenesis. His work on Antiphospholipid syndrome as part of general Antibody research is often related to Cardiolipin, thus linking different fields of science.
Donato Alarcón-Segovia focuses on Lupus erythematosus, Internal medicine, Immunology, Autoimmune disease and Genetics. His research on Lupus erythematosus often connects related areas such as Systemic lupus erythematosus. The study incorporates disciplines such as Gastroenterology and Surgery in addition to Internal medicine.
His biological study spans a wide range of topics, including Autoantibody and Autoimmunity. His Autoantibody study is focused on Antibody in general. His Connective tissue disease research incorporates themes from Chemotherapy, Biologic marker, Systemic disease, Immunopathology and Prednisone.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans
Ludmila Prokunina;Casimiro Castillejo-López;Fredrik Öberg;Iva Gunnarsson.
Nature Genetics (2002)
Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients.
Alarcón-Segovia D;Delezé M;Oria Cv;Sánchez-Guerrero J.
Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus.
Luis Llorente;Weiping Zou;Yves Levy;Yvonne Richaud-Patin.
Journal of Experimental Medicine (1995)
Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus
Luis Llorente;Yvonne Richaud-Patin;Carlos García-Padilla;Emmanuel Claret.
Arthritis & Rheumatism (2000)
Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort.
Donato Alarcón‐Segovia;Marta E. Alarcón‐Riquelme;Mario H. Cardiel;Francisco Caeiro.
Arthritis & Rheumatism (2005)
The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among "Hispanics".
Bernardo A Pons-Estel;Luis J Catoggio;Mario H Cardiel;Enrique R Soriano.
Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus
Donato Alarcón-Segovia;María Esther Pérez-Vázquez;Antonio R. Villa;Cristina Drenkard.
Seminars in Arthritis and Rheumatism (1992)
LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: results from a randomized, double-blind, placebo-controlled study.
Donato Alarcón-Segovia;James A. Tumlin;Richard A. Furie;James D. McKay.
Arthritis & Rheumatism (2003)
Antibody to nuclear ribonucleoprotein penetrates live human mononuclear cells through Fc receptors
Donato Alarcon-Segovia;Alejandro Ruiz-Arguelles;Eugenia Fishbein.
Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
J Cabiedes;A R Cabral;D Alarcón-Segovia.
The Journal of Rheumatology (1995)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: